{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T16:29:35Z","timestamp":1787243375438,"version":"build-2736575974"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,7,28]],"date-time":"2021-07-28T00:00:00Z","timestamp":1627430400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,7,28]],"date-time":"2021-07-28T00:00:00Z","timestamp":1627430400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Global Alliance to Prevent Prematurity and Stillbirth","award":["Seattle Children\u2019s Hospital\/GAPPS 13008"],"award-info":[{"award-number":["Seattle Children\u2019s Hospital\/GAPPS 13008"]}]},{"DOI":"10.13039\/100011072","name":"Center for AIDS Research, University of North Carolina at Chapel Hill","doi-asserted-by":"publisher","award":["CFAR P30 AI050410"],"award-info":[{"award-number":["CFAR P30 AI050410"]}],"id":[{"id":"10.13039\/100011072","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000061","name":"Fogarty International Center","doi-asserted-by":"publisher","award":["D43 TW009340"],"award-info":[{"award-number":["D43 TW009340"]}],"id":[{"id":"10.13039\/100000061","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000865","name":"Bill and Melinda Gates Foundation","doi-asserted-by":"publisher","award":["OPP 1203327"],"award-info":[{"award-number":["OPP 1203327"]}],"id":[{"id":"10.13039\/100000865","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["T32 HD075731"],"award-info":[{"award-number":["T32 HD075731"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["K01 TW010857"],"award-info":[{"award-number":["K01 TW010857"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Pregnancy Childbirth"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Maternal HIV increases the risk of adverse birth outcomes including preterm birth, fetal growth restriction, and stillbirth, but the biological mechanism(s) underlying this increased risk are not well understood. We hypothesized that maternal HIV may lead to adverse birth outcomes through an imbalance in angiogenic factors involved in the vascular endothelial growth factor (VEGF) signaling pathway.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>In a case\u2013control study nested within an ongoing cohort in Zambia, our primary outcomes were serum concentrations of VEGF-A, soluble endoglin (sEng), placental growth factor (PlGF), and soluble fms-like tyrosine kinase-1 (sFLT-1). These were measured in 57 women with HIV (cases) and 57 women without HIV (controls) before 16 gestational weeks. We used the Wilcoxon rank-sum and linear regression controlling for maternal body mass index (BMI) and parity to assess the difference in biomarker concentrations between cases and controls. We also used logistic regression to test for associations between biomarker concentration and adverse pregnancy outcomes (preeclampsia, preterm birth, small for gestational age, stillbirth, and a composite of preterm birth or stillbirth).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Compared to controls, women with HIV had significantly lower median concentrations of PlGF (7.6 vs 10.2\u00a0pg\/mL,\n                      <jats:italic>p\u2009<\/jats:italic>\n                      =\u20090.02) and sFLT-1 (1647.9 vs 2055.6\u00a0pg\/mL,\n                      <jats:italic>p\u2009<\/jats:italic>\n                      =\u20090.04), but these findings were not confirmed in adjusted analysis. PlGF concentration was lower among women who delivered preterm compared to those who delivered at term (6.7 vs 9.6\u00a0pg\/mL,\n                      <jats:italic>p\u2009<\/jats:italic>\n                      =\u20090.03) and among those who experienced the composite adverse birth outcome (6.2 vs 9.8\u00a0pg\/mL,\n                      <jats:italic>p\u2009<\/jats:italic>\n                      =\u20090.02). Median sFLT-1 concentration was lower among participants with the composite outcome (1621.0 vs 1945.9\u00a0pg\/mL,\n                      <jats:italic>p\u2009<\/jats:italic>\n                      =\u20090.04), but the association was not significant in adjusted analysis. sEng was not associated with either adverse birth outcomes or HIV. VEGF-A was undetectable by Luminex in all specimens.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>We present preliminary findings that HIV is associated with a shift in the VEGF signaling pathway in early pregnancy, although adjusted analyses were inconclusive. We confirm an association between angiogenic biomarkers and adverse birth outcomes in our population. Larger studies are needed to further elucidate the role of HIV on placental angiogenesis and adverse birth outcomes.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12884-021-03965-5","type":"journal-article","created":{"date-parts":[[2021,7,28]],"date-time":"2021-07-28T05:03:16Z","timestamp":1627448596000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Circulating angiogenic factors and HIV among pregnant women in Zambia: a nested case\u2013control study"],"prefix":"10.1186","volume":"21","author":[{"given":"Megan E.","family":"Smithmyer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chileshe M.","family":"Mabula-Bwalya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Humphrey","family":"Mwape","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriel","family":"Chipili","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bridget M.","family":"Spelke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margaret P.","family":"Kasaro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristina","family":"De Paris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bellington","family":"Vwalika","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuri V.","family":"Sebasti\u00e3o","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey S.A.","family":"Stringer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joan T.","family":"Price","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,7,28]]},"reference":[{"key":"3965_CR1","volume-title":"The gap report","author":"UN Joint Programme on HIV\/AIDS (UNAIDS)","year":"2014","unstructured":"UN Joint Programme on HIV\/AIDS (UNAIDS). The gap report. Geneva: UNAIDS; 2014. https:\/\/www.refworld.org\/docid\/53f1e1604.html [Accessed 28 May 2019]."},{"key":"3965_CR2","doi-asserted-by":"publisher","first-page":"e33","DOI":"10.1016\/S2352-3018(15)00207-6","volume":"3","author":"COO Wedi","year":"2016","unstructured":"Wedi COO, Kirtley S, Hopewell S, Corrigan R, Kennedy SH, Hemelaar J. Perinatal outcomes associated with maternal HIV infection: A systematic review and meta-analysis. Lancet HIV. 2016;3:e33-48.","journal-title":"Lancet HIV"},{"key":"3965_CR3","doi-asserted-by":"publisher","unstructured":"Obimbo MM, Zhou Y, Mcmaster MT, Cohen CR, Qureshi Z, Ong\u2019ech J, et al. Placental structure in preterm birth amongst HIV positive versus negative women in Kenya. JAIDS J Acquir Immune Defic Syndr. 2018;1. doi:https:\/\/doi.org\/10.1097\/QAI.0000000000001871.","DOI":"10.1097\/QAI.0000000000001871"},{"key":"3965_CR4","doi-asserted-by":"publisher","first-page":"604","DOI":"10.1111\/tmi.12858","volume":"22","author":"E Kalk","year":"2017","unstructured":"Kalk E, Schubert P, Bettinger JA, Cotton MF, Esser M, Slogrove A, et al. Placental pathology in HIV infection at term: a comparison with HIV-uninfected women. Trop Med Int Heal. 2017;22:604\u201313.","journal-title":"Trop Med Int Heal"},{"key":"3965_CR5","doi-asserted-by":"publisher","first-page":"684.e1","DOI":"10.1016\/j.ajog.2017.10.003","volume":"217","author":"AL Conroy","year":"2017","unstructured":"Conroy AL, McDonald CR, Gamble JL, Olwoch P, Natureeba P, Cohan D, et al. Altered angiogenesis as a common mechanism underlying preterm birth, small for gestational age, and stillbirth in women living with HIV. Am J Obstet Gynecol. 2017;217:684.e1-684.e17. https:\/\/doi.org\/10.1016\/j.ajog.2017.10.003.","journal-title":"Am J Obstet Gynecol"},{"key":"3965_CR6","doi-asserted-by":"publisher","first-page":"174","DOI":"10.5830\/CVJA-2013-029","volume":"24","author":"N Govender","year":"2013","unstructured":"Govender N, Naicker T, Moodley J. Maternal imbalance between pro-angiogenic and anti-angiogenic factors in HIV-infected women with pre-eclampsia. Cardiovasc J Afr. 2013;24:174\u20139.","journal-title":"Cardiovasc J Afr"},{"key":"3965_CR7","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1016\/j.acthis.2007.02.008","volume":"109","author":"R Demir","year":"2007","unstructured":"Demir R, Seval Y, Huppertz B. Vasculogenesis and angiogenesis in the early human placenta. Acta Histochem. 2007;109:257\u201365.","journal-title":"Acta Histochem"},{"key":"3965_CR8","doi-asserted-by":"publisher","first-page":"2934","DOI":"10.1096\/fj.201700867RR","volume":"32","author":"H Tian","year":"2018","unstructured":"Tian H, Huang JJ, Golzio C, Gao X, Hector-Greene M, Katsanis N, et al. Endoglin interacts with VEGFR2 to promote angiogenesis. FASEB J. 2018;32:2934\u201349.","journal-title":"FASEB J"},{"key":"3965_CR9","doi-asserted-by":"crossref","unstructured":"Kaitu\u2019u-Lino TJ, Whitehead CL, Ngian GL, Permezel M, Tong S. Serum concentrations of soluble flt-1 are decreased among women with a viable fetus and no symptoms of miscarriage destined for pregnancy loss. PLoS One. 2012;7(2):e32509.","DOI":"10.1371\/journal.pone.0032509"},{"key":"3965_CR10","doi-asserted-by":"publisher","first-page":"2681","DOI":"10.1093\/humrep\/dew225","volume":"31","author":"CN Jayasena","year":"2016","unstructured":"Jayasena CN, Abbara A, Comninos AN, Narayanaswamy S, Maffe JG, Izzi-Engbeaya C, et al. Novel circulating placental markers prokineticin-1, soluble fms-like tyrosine kinase-1, soluble endoglin and placental growth factor and association with late miscarriage. Hum Reprod. 2016;31:2681\u20138.","journal-title":"Hum Reprod"},{"key":"3965_CR11","doi-asserted-by":"publisher","first-page":"1444","DOI":"10.1210\/jc.2011-0037","volume":"96","author":"A Daponte","year":"2011","unstructured":"Daponte A, Pournaras S, Polyzos NP, Tsezou A, Skentou H, Anastasiadou F, et al. Soluble fms-like tyrosine kinase-1 (sFlt-1) and serum placental growth factor (PlGF) as biomarkers for ectopic pregnancy and missed abortion. J Clin Endocrinol Metab. 2011;96:1444\u201351.","journal-title":"J Clin Endocrinol Metab"},{"key":"3965_CR12","doi-asserted-by":"publisher","first-page":"1316","DOI":"10.1097\/01.AOG.0000265804.09161.0d","volume":"109","author":"GCS Smith","year":"2007","unstructured":"Smith GCS, Crossley JA, Aitken DA, Jenkins N, Lyall F, Cameron AD, et al. Circulating angiogenic factors in early pregnancy and the risk of preeclampsia, intrauterine growth restriction, spontaneous preterm birth, and stillbirth. Obstet Gynecol. 2007;109:1316\u201324.","journal-title":"Obstet Gynecol"},{"key":"3965_CR13","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1093\/aje\/kwq373","volume":"173","author":"BO Asvold","year":"2011","unstructured":"Asvold BO, Vatten LJ, Romundstad PR, Jenum PA, Karumanchi SA, Eskild A. Angiogenic factors in maternal circulation and the risk of severe fetal growth restriction. Am J Epidemiol. 2011;173:630\u20139.","journal-title":"Am J Epidemiol"},{"key":"3965_CR14","doi-asserted-by":"publisher","first-page":"1384","DOI":"10.3109\/14767051003681121","volume":"23","author":"R Romero","year":"2010","unstructured":"Romero R, Chaiworapongsa T, Erez O, Tarca AL, Gervasi MT, Kusanovic JP, et al. An imbalance between angiogenic and anti-angiogenic factors precedes fetal death in a subset of patients: Results of a longitudinal study. J Matern Neonatal Med. 2010;23:1384\u201399.","journal-title":"J Matern Neonatal Med"},{"key":"3965_CR15","doi-asserted-by":"crossref","unstructured":"Castillo MC, Fuseini NM, Rittenhouse K, Price JT, Freeman BL, Mwape H, et al. Zambian Preterm Birth Prevention Study (ZAPPS): cohort characteristics at enrollment. Gates Open Res. 2019;2:25.","DOI":"10.12688\/gatesopenres.12820.3"},{"key":"3965_CR16","doi-asserted-by":"publisher","first-page":"1533","DOI":"10.12688\/gatesopenres.13046.1","volume":"3","author":"JT Price","year":"2019","unstructured":"Price JT, Vwalika B, Rittenhouse KJ, Mwape H, Winston J, Freeman BL, et al. Adverse birth outcomes and their clinical phenotypes in an urban Zambian cohort. Gates Open Res. 2019;3:1533.","journal-title":"Gates Open Res"},{"key":"3965_CR17","doi-asserted-by":"publisher","first-page":"1244","DOI":"10.1111\/j.1600-0412.2011.01186.x","volume":"90","author":"M Palm","year":"2011","unstructured":"Palm M, Basu S, Larsson A, Wernroth L, \u00c5kerud H, Axelsson O. A longitudinal study of plasma levels of soluble fms-like tyrosine kinase 1 (sFlt1), placental growth factor (PlGF), sFlt1: PlGF ratio and vascular endothelial growth factor (VEGF-A) in normal pregnancy. Acta Obstet Gynecol Scand. 2011;90:1244\u201351.","journal-title":"Acta Obstet Gynecol Scand"},{"key":"3965_CR18","doi-asserted-by":"publisher","first-page":"19009","DOI":"10.3390\/ijms160819009","volume":"16","author":"I Herraiz","year":"2015","unstructured":"Herraiz I, Sim\u00f3n E, G\u00f3mez-Arriaga PI, Mart\u00ednez-Moratalla JM, Garc\u00eda-Burguillo A, L\u00f3pez Jim\u00e9nez EA, et al. Angiogenesis-related biomarkers (sFlt-1\/PLGF) in the prediction and diagnosis of placental dysfunction: An approach for clinical integration. Int J Mol Sci. 2015;16:19009\u201326.","journal-title":"Int J Mol Sci"},{"key":"3965_CR19","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/j.ajog.2011.10.865","volume":"206","author":"RL Goldenberg","year":"2012","unstructured":"Goldenberg RL, Gravett MG, Iams J, Papageorghiou AT, Waller SA, Kramer M, et al. The preterm birth syndrome: Issues to consider in creating a classification system. Am J Obstet Gynecol. 2012;206:113\u20138. https:\/\/doi.org\/10.1016\/j.ajog.2011.10.865.","journal-title":"Am J Obstet Gynecol"},{"key":"3965_CR20","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1016\/j.ajog.2011.10.864","volume":"206","author":"MS Kramer","year":"2012","unstructured":"Kramer MS, Papageorghiou A, Culhane J, Bhutta Z, Goldenberg RL, Gravett M, et al. Challenges in defining and classifying the preterm birth syndrome. Am J Obstet Gynecol. 2012;206:108\u201312.","journal-title":"Am J Obstet Gynecol"},{"key":"3965_CR21","doi-asserted-by":"publisher","first-page":"S630","DOI":"10.1016\/j.ajog.2018.01.011","volume":"218","author":"AT Papageorghiou","year":"2018","unstructured":"Papageorghiou AT, Kennedy SH, Salomon LJ, Altman DG, Ohuma EO, Stones W, et al. The INTERGROWTH-21st fetal growth standards: toward the global integration of pregnancy and pediatric care. Am J Obstet Gynecol. 2018;218:S630\u201340. https:\/\/doi.org\/10.1016\/j.ajog.2018.01.011.","journal-title":"Am J Obstet Gynecol"},{"key":"3965_CR22","doi-asserted-by":"publisher","first-page":"153","DOI":"10.5830\/CVJA-2012-003","volume":"23","author":"L Govender","year":"2012","unstructured":"Govender L, Mackraj I, Gathiram P, Moodley J. The role of angiogenic, anti-angiogenic and vasoactive factors in pre-eclamptic African women: Early- versus late-onset pre-eclampsia. Cardiovasc J Afr. 2012;23:153\u20139.","journal-title":"Cardiovasc J Afr"},{"key":"3965_CR23","doi-asserted-by":"publisher","first-page":"247.e1","DOI":"10.1016\/j.ajog.2014.03.020","volume":"211","author":"CA Zera","year":"2014","unstructured":"Zera CA, Seely EW, Wilkins-Haug LE, Lim KH, Parry SI, McElrath TF. The association of body mass index with serum angiogenic markers in normal and abnormal pregnancies. Am J Obstet Gynecol. 2014;211:247.e1-247.e7. https:\/\/doi.org\/10.1016\/j.ajog.2014.03.020.","journal-title":"Am J Obstet Gynecol"},{"key":"3965_CR24","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/j.placenta.2003.10.010","volume":"25","author":"TM Mayhew","year":"2004","unstructured":"Mayhew TM, Charnock-Jones DS, Kaufmann P. Aspects of human fetoplacental vasculogenesis and angiogenesis III Changes in complicated pregnancies. Placenta. 2004;25:127\u201339.","journal-title":"Placenta"},{"key":"3965_CR25","first-page":"97","volume":"23","author":"M Chuchracki","year":"2017","unstructured":"Chuchracki M, Krzyscin M, Dera-Szymanowska A, Pisarska M, Florek E, Breborowicz GH. The role of sFLT-1 and PlGF factors as well as the sFLT-1\/PlGF ratio as a predictor of gestational hypertension and preeclampsia. Arch Perinat Med. 2017;23:97\u2013104.","journal-title":"Arch Perinat Med"},{"key":"3965_CR26","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1002\/ijgo.12686","volume":"144","author":"JT Price","year":"2019","unstructured":"Price JT, Winston J, Vwalika B, Cole SR, Stoner MCD, Lubeya MK, et al. Quantifying bias between reported last menstrual period and ultrasonography estimates of gestational age in Lusaka. Zambia Int J Gynecol Obstet. 2019;144:9\u201315.","journal-title":"Zambia Int J Gynecol Obstet"}],"container-title":["BMC Pregnancy and Childbirth"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12884-021-03965-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12884-021-03965-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12884-021-03965-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,28]],"date-time":"2021-07-28T05:06:35Z","timestamp":1627448795000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpregnancychildbirth.biomedcentral.com\/articles\/10.1186\/s12884-021-03965-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7,28]]},"references-count":26,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["3965"],"URL":"https:\/\/doi.org\/10.1186\/s12884-021-03965-5","relation":{},"ISSN":["1471-2393"],"issn-type":[{"value":"1471-2393","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,7,28]]},"assertion":[{"value":"15 October 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 June 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 July 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All ZAPPS participants provide individual written informed consent before undergoing study procedures. The University of Zambia Biomedical Research Ethics Committee, the National Health Research Authority of the Zambian Ministry of Health, and the University of North Carolina at Chapel Hill Institutional Review Board each approved the use of these clinical data and biological specimens for research purposes.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"534"}}